Paris, France

Efroim Steiner

This inventor holds 1 USPTO granted patent. Top assignee: Centre Europeen De Recherches Mauvernay. Active years: 1980.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Efroim Steiner. Retrieved from https://idiyas.com/inventor/efroim-steiner

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 1980

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Efroim Steiner: Innovator in Pharmaceutical Chemistry

Introduction

Efroim Steiner is a notable inventor based in Paris, France. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel drug compounds. His work focuses on the treatment of inflammatory syndromes, showcasing his commitment to advancing medical science.

Latest Patents

Steiner holds a patent for "Derivatives of 4-cyclohexyl-1-naphthalene-acetic acid and their use." This invention relates to derivatives of 4-cyclohexyl-1-naphthalene-acetic acid, where R is a lower alkyl group, along with pharmaceutically acceptable salts and derivatives. The invention also encompasses pharmaceutical compositions containing such derivatives, which are useful as drugs for treating inflammatory syndromes. He has 1 patent to his name.

Career Highlights

Steiner is associated with the Centre Européen de Recherches Mauvernay, where he conducts his research and development activities. His work at this institution has allowed him to explore innovative solutions in drug development.

Collaborations

One of his notable collaborators is Jean-Jacques Godfroid, with whom he has worked on various projects aimed at enhancing pharmaceutical efficacy.

Conclusion

Efroim Steiner's contributions to pharmaceutical chemistry highlight his innovative spirit and dedication to improving healthcare. His work continues to influence the development of effective treatments for inflammatory conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…